1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

venBio Select Advisor LLC Buys Karyopharm Therapeutics Inc, Pacira BioSciences Inc, Athenex Inc, Sells Array BioPharma Inc, The Medicines Co, ACADIA Pharmaceuticals Inc

San Francisco, CA, based Investment company venBio Select Advisor LLC (Current Portfolio) buys Karyopharm Therapeutics Inc, Pacira BioSciences Inc, Athenex Inc, uniQure NV, Adverum Biotechnologies Inc, sells Array BioPharma Inc, The Medicines Co, ACADIA Pharmaceuticals Inc, Adaptive Biotechnologies Corp, Intec Pharma during the 3-months ended 2019Q3, according to the most recent filings of the investment company, venBio Select Advisor LLC. As of 2019Q3, venBio Select Advisor LLC owns 32 stocks with a total value of $2.4 billion. These are the details of the buys and sells.

For the details of venBio Select Advisor LLC's stock buys and sells, go to https://www.gurufocus.com/guru/venbio+select+advisor+llc/current-portfolio/portfolio

These are the top 5 holdings of venBio Select Advisor LLC
  1. Mirati Therapeutics Inc (MRTX) - 3,750,000 shares, 12.35% of the total portfolio. Shares reduced by 2.91%
  2. Immunomedics Inc (IMMU) - 21,000,000 shares, 11.77% of the total portfolio.
  3. Iovance Biotherapeutics Inc (IOVA) - 10,601,039 shares, 8.15% of the total portfolio. Shares reduced by 1.41%
  4. Ascendis Pharma A/S (ASND) - 1,970,000 shares, 8.02% of the total portfolio.
  5. Biomarin Pharmaceutical Inc (BMRN) - 2,437,100 shares, 6.94% of the total portfolio. Shares added by 15.23%
New Purchase: Karyopharm Therapeutics Inc (KPTI)

venBio Select Advisor LLC initiated holding in Karyopharm Therapeutics Inc. The purchase prices were between $5.66 and $11.85, with an estimated average price of $9.03. The stock is now traded at around $15.36. The impact to a portfolio due to this purchase was 2.46%. The holding were 6,050,000 shares as of .

New Purchase: uniQure NV (QURE)

venBio Select Advisor LLC initiated holding in uniQure NV. The purchase prices were between $39.36 and $76.8, with an estimated average price of $57.9. The stock is now traded at around $52.56. The impact to a portfolio due to this purchase was 0.61%. The holding were 365,000 shares as of .

New Purchase: Turning Point Therapeutics Inc (TPTX)

venBio Select Advisor LLC initiated holding in Turning Point Therapeutics Inc. The purchase prices were between $36.9 and $57.76, with an estimated average price of $43.7. The stock is now traded at around $49.40. The impact to a portfolio due to this purchase was 0.16%. The holding were 100,000 shares as of .

Added: Pacira BioSciences Inc (PCRX)

venBio Select Advisor LLC added to a holding in Pacira BioSciences Inc by 300.00%. The purchase prices were between $35.66 and $44.99, with an estimated average price of $39.92. The stock is now traded at around $42.58. The impact to a portfolio due to this purchase was 1.93%. The holding were 1,600,000 shares as of .

Added: Athenex Inc (ATNX)

venBio Select Advisor LLC added to a holding in Athenex Inc by 27.90%. The purchase prices were between $12.17 and $21, with an estimated average price of $16.36. The stock is now traded at around $11.23. The impact to a portfolio due to this purchase was 0.66%. The holding were 5,890,000 shares as of .

Added: Adverum Biotechnologies Inc (ADVM)

venBio Select Advisor LLC added to a holding in Adverum Biotechnologies Inc by 21.43%. The purchase prices were between $5.24 and $15.89, with an estimated average price of $11.26. The stock is now traded at around $9.01. The impact to a portfolio due to this purchase was 0.17%. The holding were 4,250,000 shares as of .

Sold Out: Array BioPharma Inc (ARRY)

venBio Select Advisor LLC sold out a holding in Array BioPharma Inc. The sale prices were between $46.24 and $47.85, with an estimated average price of $46.79.

Sold Out: Adaptive Biotechnologies Corp (ADPT)

venBio Select Advisor LLC sold out a holding in Adaptive Biotechnologies Corp. The sale prices were between $30.31 and $53.51, with an estimated average price of $40.94.

Sold Out: Intec Pharma Ltd (NTEC)

venBio Select Advisor LLC sold out a holding in Intec Pharma Ltd. The sale prices were between $0.43 and $4.17, with an estimated average price of $1.36.



Here is the complete portfolio of venBio Select Advisor LLC. Also check out:

1. venBio Select Advisor LLC's Undervalued Stocks
2. venBio Select Advisor LLC's Top Growth Companies, and
3. venBio Select Advisor LLC's High Yield stocks
4. Stocks that venBio Select Advisor LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)